ArticleFrontiers in oncology2026
Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiation-induced dermatitis (RID) is a common toxicity in patients with nasopharyngeal carcinoma (NPC) undergoing radiotherapy. This study aimed to evaluate the incidence, onset time, and factors associated with severe RID in patients with NPC. Methods: This retrospective study included 287 patients with histologically confirmed NPC who received radiotherapy between August 2020 and August 2025. RID was graded according to the Radiation Therapy Oncology Group (RTOG) acute radiation morbidity criteria. Severe RID was defined as RTOG grade ≥3. Patients were classified into non-severe RID (RTOG grade 0-2) and severe RID groups. Baseline, clinicopathological, treatment-related, and laboratory variables were compared between groups. Logistic regression was used to identify factors associated with severe RID. Results: Patients were stratified into a non-severe group (RTOG grade 0-2, n = 201) and a severe group (RTOG grade ≥3, n = 86). The mean onset time was 24.8 ± 6.7 days for RTOG grade ≥1 RID and 37.6 ± 6.3 days for RTOG grade ≥3 RID. In multivariable analysis, older age (odds ratio [OR] = 1.03, 95% confidence interval [CI]: 1.01-1.06), smoking history (OR = 1.93, 95% CI: 1.11-3.55), higher total radiation dose (OR = 1.08, 95% CI: 1.01-1.15), elevated C-reactive protein (OR = 1.12, 95% CI: 1.06-1.20), higher neutrophil-to-lymphocyte ratio (OR = 1.53, 95% CI: 1.21-1.96), and larger irradiation area (OR = 1.16, 95% CI: 1.06-1.28) were positively associated with severe RID, whereas higher albumin was inversely associated with severe RID (OR = 0.89, 95% CI: 0.82-0.95). Conclusions: Severe radiation-induced dermatitis was observed in 30.0% of patients with nasopharyngeal carcinoma receiving radiotherapy. Older age, smoking history, higher radiation dose, elevated inflammatory status, larger irradiation area, and lower albumin level were independently associated with severe radiation-induced dermatitis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.